ColciGel®: A Superior Alternative for Acute Gout Flares
نویسندگان
چکیده
ColciGel® A new agent, ColciGel®, has recently emerged for the treatment of acute flares of gout. ColciGel is a transdermal gel preparation of Colchicinum (colchicine in its homeopathic state) that is applied topically. ColciGel contains Colchicinum 4X in a proprietary Organogel that is applied directly to the site of acute flares. It is supplied as an airless 15ml container that delivers 0.25 ml of ColciGel® per pump. When ColciGel® is applied to the site of the acute gout flare, it crosses the dermal layer and reduces the inflammation and pain associated with the flare. With the topical application of ColciGel®, only minimal amounts of colchicine enter systemic circulation, reaching sub-clinical concentrations of <50 pg/mL. The combination of avoiding the gastrointestinal (GI) system and sub-clinical systemic circulation allows ColciGel® to avoid the tolerability and safety issues commonly seen with oral colchicine. ColciGel® patients report a 50% or greater decrease in pain and inflammation within a few hours and improved pain relief with additional applications. The typical GI side effects usually seen with oral colchicine have not been observed with transdermal ColciGel®.
منابع مشابه
Pilot Studies of Cherry Juice Concentrate for Gout Flare Prophylaxis
Gout is the most common inflammatory arthritis in men and older women. The management of gout involves treating pain and inflammation associated with acute flares and lowering the uric acid pool. A challenge associated with the successful management of gout is an increased risk of acute flares after initiation of urate-lowering therapy (ULT). Prophylactic anti-inflammatory therapy is recommende...
متن کاملTreatment of Gout
In France, colchicine remains the standard treatment for the acute flare of gout. The lowest dose currently used decreases digestive toxicity. Doses of colchicine should be adapted to renal function and age, and possible drug interactions should be considered. Non steroidal anti-inflammatory drugs are an alternative to colchicine, but their use is frequently limited by comorbidity. When these t...
متن کاملProphylaxis for acute gout flares after initiation of urate-lowering therapy.
This review summarizes evidence relating to prophylaxis for gout flares after the initiation of urate-lowering therapy (ULT). We searched MEDLINE via PubMed for articles published in English from 1963 to 2013 using MEsH terms covering all aspects of prophylaxis for flares. Dispersion of monosodium urate crystals during the initial phase of deposit dissolution with ULT exposes the patient to an ...
متن کاملFoot pain, impairment, and disability in patients with acute gout flares: A prospective observational study.
OBJECTIVE To evaluate the impact of acute gout on foot pain, impairment, and disability. METHODS This prospective observational study recruited 20 patients with acute gout flares. Patients were recruited from emergency departments, hospital wards, and rheumatology outpatient clinics throughout Auckland, New Zealand. Patients were recruited at the time of the flare (baseline visit) and then re...
متن کاملTophi and frequent gout flares are associated with impairments to quality of life, productivity, and increased healthcare resource use: Results from a cross-sectional survey
BACKGROUND The prevalence of gout is increasing, and most research on the associated burden has focused on serum urate (sUA) levels. The present study quantifies the impact of the presence of tophi and frequency of acute gout attacks on health-related quality of life (HRQOL), productivity, and healthcare resource utilization. METHODS Patients with self-reported gout (n=620; 338 in US and 282 ...
متن کامل